Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Olmesartan medoxomil 20mg / Amlodipine 5mg tablets
0205052ABAAAAAA
|
Olmesartan medoxomil/amlodipine | Olmesartan medoxomil/amlodipine | Cardiovascular System | 2,257 |
|
Olmesartan medoxomil 40mg / Amlodipine 10mg tablets
0205052ABAAACAC
|
Olmesartan medoxomil/amlodipine | Olmesartan medoxomil/amlodipine | Cardiovascular System | 1,547 |
|
Olmesartan medoxomil 40mg / Amlodipine 5mg tablets
0205052ABAAABAB
|
Olmesartan medoxomil/amlodipine | Olmesartan medoxomil/amlodipine | Cardiovascular System | 1,137 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.